Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
25 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/acceleration-in-clinical-development-leads-biolabs-lbl-034-dosed-first-patient-in-phase--trial-302537572.html
14 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/leads-biolabs-announces-completion-of-patient-enrollment-in-pivotal-trial-of-opamtistomig-monotherapy-for-extrapulmonary-neuroendocrine-carcinoma-302530006.html
25 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/chinese-antibody-developer-leads-biolabs-hits-hong-kong-stock-exchange-189m-ipo
24 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/leads-biolabs-lists-on-hkex-raising-usd-189-million-through-initial-public-offering-302512730.html
31 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/breakthrough-clinical-data-for-lbl-024-in-first-line-treatment-of-advanced-ep-nec-unveiled-at-2025-asco-oral-session-302466588.html
22 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-granted-orphan-drug-designation-of-lbl-024-an-anti-pd-l14-1bb-bispecific-antibody-developed-by-leads-biolabs-for-treatment-of-neuroendocrine-cancer-302314012.html
ABOUT THIS PAGE